Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNeurocentre Magendie, Physiopathologie de la plasticité neuronale, U862
dc.contributor.authorDURAND, Christelle M.
hal.structure.identifierInstitut de Génomique Fonctionnelle [IGF]
dc.contributor.authorPERROY, Julie
hal.structure.identifierNeurocentre Magendie, Physiopathologie de la plasticité neuronale, U862
dc.contributor.authorLOLL, Francois
dc.contributor.authorPERRAIS, David
hal.structure.identifierInstitut de Génomique Fonctionnelle [IGF]
dc.contributor.authorFAGNI, Laurent
hal.structure.identifierGénétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions [GHFC (UMR_3571 / U-Pasteur_1)]
dc.contributor.authorBOURGERON, Thomas
hal.structure.identifierNeurocentre Magendie, Physiopathologie de la plasticité neuronale, U862
dc.contributor.authorMONTCOUQUIOL, Mireille
hal.structure.identifierNeurocentre Magendie, Physiopathologie de la plasticité neuronale, U862
dc.contributor.authorSANS, Nathalie
dc.date.accessioned2022-06-30T08:27:14Z
dc.date.available2022-06-30T08:27:14Z
dc.date.issued2011-05-24
dc.identifier.issn1359-4184en_US
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/21606927
dc.identifier.uriftpubmed:oai:pubmedcentral.nih.gov:3252613
dc.identifier.urioai:researchgate.net:51160367
dc.identifier.urioadoi:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252613
dc.identifier.urioadoi:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252613/pdf
dc.identifier.urioai:crossref.org:10.1038/mp.2011.57
dc.identifier.urioadoi:http://europepmc.org/articles/pmc3252613?pdf=render
dc.identifier.urioadoi:https://hal.archives-ouvertes.fr/hal-00644264/document
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/140341
dc.description.abstractEnGenetic mutations of SHANK3 have been reported in patients with intellectual disability, autism spectrum disorder (ASD) and schizophrenia. At the synapse, Shank3/ProSAP2 is a scaffolding protein that connects glutamate receptors to the actin cytoskeleton via a chain of intermediary elements. Although genetic studies have repeatedly confirmed the association of SHANK3 mutations with susceptibility to psychiatric disorders, very little is known about the neuronal consequences of these mutations. Here, we report the functional effects of two de novo mutations (STOP and Q321R) and two inherited variations (R12C and R300C) identified in patients with ASD. We show that Shank3 is located at the tip of actin filaments and enhances its polymerization. Shank3 also participates in growth cone motility in developing neurons. The truncating mutation (STOP) strongly affects the development and morphology of dendritic spines, reduces synaptic transmission in mature neurons and also inhibits the effect of Shank3 on growth cone motility. The de novo mutation in the ankyrin domain (Q321R) modifies the roles of Shank3 in spine induction and morphology, and actin accumulation in spines and affects growth cone motility. Finally, the two inherited mutations (R12C and R300C) have intermediate effects on spine density and synaptic transmission. Therefore, although inherited by healthy parents, the functional effects of these mutations strongly suggest that they could represent risk factors for ASD. Altogether, these data provide new insights into the synaptic alterations caused by SHANK3 mutations in humans and provide a robust cellular readout for the development of knowledge-based therapies.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.sourcebase
dc.sourceresearchgate
dc.sourceoadoi_repo
dc.sourcecrossref
dc.subject.enActin
dc.subject.enAutism
dc.subject.enAxonal outgrowth
dc.subject.enHippocampus
dc.subject.enShank3
dc.subject.enSpine
dc.title.enSHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/mp.2011.57en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
bordeaux.journalMolecular Psychiatryen_US
bordeaux.page71-84en_US
bordeaux.volume17en_US
bordeaux.hal.laboratoriesNeurocentre Magendie - UMR-S 1215en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPolarité planaire et plasticitéen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDConseil Régional Aquitaineen_US
bordeaux.identifier.funderIDFondation pour la Recherche Médicaleen_US
bordeaux.import.sourcedissemin
hal.exportfalse
workflow.import.sourcedissemin
dc.rights.ccCC BY-NC-NDen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Molecular%20Psychiatry&rft.date=2011-05-24&rft.volume=17&rft.issue=1&rft.spage=71-84&rft.epage=71-84&rft.eissn=1359-4184&rft.issn=1359-4184&rft.au=DURAND,%20Christelle%20M.&PERROY,%20Julie&LOLL,%20Francois&PERRAIS,%20David&FAGNI,%20Laurent&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée